Acute Hemorrhagic Enterotoxemia (Clostridium perfringens Type C)

Acute hemorrhagic enterotoxemia (AHE) is a rapidly fatal, toxemic disease of sheep and goats caused by Clostridium perfringens type C, an anaerobic, spore-forming, Gram-positive bacillus that produces beta toxin as its primary virulence factor. The disease is characterized by sudden death, severe hemorrhagic enteritis, and systemic toxemia, primarily affecting neonatal lambs and kids within the first few days of life, although sporadic cases can occur in older animals under specific predisposing conditions. In the context of small ruminant medicine, AHE is a major cause of neonatal mortality, particularly in intensively managed flocks with high stocking density and inadequate passive transfer of immunity. The disease is classified under digestive and metabolic disorders due to its profound impact on the gastrointestinal tract and the systemic metabolic derangements that ensue from toxin-mediated vascular damage and tissue necrosis. Economically, AHE results in significant losses due to death of replacement stock, treatment costs, and reduced flock productivity, especially in flocks with endemic clostridial contamination. The disease is distinct from other enterotoxemias caused by C. perfringens types A, B, D, and E, each associated with different toxins and clinical syndromes. In neonatal ruminants, type C infection is particularly devastating because beta toxin is highly sensitive to trypsin, and the neonatal intestine has low trypsin activity, allowing the toxin to exert its necrotizing effects on the intestinal mucosa. The clinical presentation ranges from peracute death without premonitory signs to acute hemorrhagic diarrhea, abdominal pain, and neurological signs, with a case fatality rate approaching 100% in untreated animals. Early recognition and prompt intervention are critical, but prevention through maternal vaccination and proper colostrum management remains the cornerstone of control.

The primary causative agent of acute hemorrhagic enterotoxemia is Clostridium perfringens type C, a Gram-positive, anaerobic, spore-forming rod that is a normal inhabitant of the soil and the gastrointestinal tract of mammals. The organism produces several exotoxins, but beta toxin is the major virulence factor responsible for the hemorrhagic and necrotizing enteritis characteristic of the disease. Beta toxin is a pore-forming protein that targets intestinal epithelial cells and vascular endothelium, leading to cell death, increased vascular permeability, and severe hemorrhage. The toxin is highly susceptible to proteolytic enzymes, particularly trypsin, which explains the higher susceptibility of neonates, as their pancreatic trypsin secretion is immature and colostrum contains trypsin inhibitors. Other toxins produced by type C include alpha toxin (phospholipase C), which contributes to tissue damage and hemolysis, and perfringolysin O, which may enhance the pathogenicity. The organism proliferates rapidly in the small intestine when conditions favor its overgrowth, such as sudden changes in diet, overeating, or intestinal stasis. In neonatal lambs and kids, infection often occurs through ingestion of spores from contaminated environment, bedding, or the dam's perineal area. The spores germinate in the intestinal lumen, and the vegetative cells multiply and produce toxins in large quantities. The disease is not contagious in the classical sense, but the spores are ubiquitous in the environment, making it a management-related disease. In older animals, type C enterotoxemia can occur secondary to dietary indiscretion, such as sudden access to high-protein or high-energy feeds, or in association with other enteric infections that alter the intestinal environment. Additionally, C. perfringens type C has been implicated in cases of hemorrhagic enteritis in adult sheep and goats, particularly in feedlot operations or when animals are fed high-concentrate rations. The organism is also associated with necrotic enteritis in poultry, but in small ruminants, the clinical syndrome is distinct. Laboratory confirmation requires isolation of the organism from intestinal contents and demonstration of beta toxin via ELISA or PCR, as well as histopathological evidence of hemorrhagic enteritis.

Acute hemorrhagic enterotoxemia caused by C. perfringens type C is a significant cause of neonatal mortality in sheep and goats worldwide, with a higher prevalence in intensively managed flocks and in regions with high soil contamination. The disease primarily affects lambs and kids from birth to about two weeks of age, with the highest incidence in the first 72 hours of life. The susceptibility of neonates is attributed to the lack of functional trypsin in the intestinal lumen, which allows beta toxin to remain active. Additionally, the immature intestinal epithelium is more vulnerable to toxin-mediated damage. Breed differences have been reported, with some breeds, such as the Suffolk and Texel, being more susceptible, possibly due to differences in intestinal physiology or passive transfer of immunity. Goat kids are also highly susceptible, and the disease can cause severe losses in dairy goat operations. The epidemiology is influenced by management practices, including the timing of colostrum ingestion, the level of maternal vaccination, and the hygiene of the lambing/kidding environment. Flocks with inadequate vaccination programs or poor colostrum management have higher morbidity and mortality rates. The disease is more common in winter and early spring when lambing/kidding seasons peak, and in flocks with high stocking density, where environmental contamination with spores is high. Morbidity rates can reach 10-30% in affected flocks, and mortality rates among affected animals are often 100% if untreated. In adult sheep and goats, the disease is sporadic but can occur in outbreaks when there is a sudden change in diet, such as introduction to lush pasture or high-concentrate feeding. The economic impact includes direct losses from death, treatment costs, and reduced weaning weights of surviving lambs/kids. Additionally, the disease can have a negative impact on flock reputation and marketability. In endemic areas, the disease is a major constraint to sheep and goat production, and control measures focus on vaccination and improved neonatal care.

The pathophysiology of acute hemorrhagic enterotoxemia begins with the ingestion of C. perfringens type C spores by a susceptible neonate. The spores germinate in the small intestine, and the vegetative cells multiply rapidly, producing beta toxin and other exotoxins. Beta toxin binds to the intestinal epithelial cells and vascular endothelium, forming pores in the cell membranes, leading to cell lysis and necrosis. The toxin also induces apoptosis and disrupts the integrity of the intestinal barrier, allowing the toxin and other bacterial products to enter the systemic circulation. The vascular damage results in increased permeability, leading to hemorrhage into the intestinal lumen and submucosa. The affected intestinal segments, typically the jejunum and ileum, become edematous, hemorrhagic, and necrotic, with a characteristic 'paintbrush' appearance on serosal surfaces. The release of toxins into the bloodstream causes systemic toxemia, characterized by shock, disseminated intravascular coagulation (DIC), and multi-organ failure. The systemic effects are exacerbated by the release of pro-inflammatory cytokines and the activation of complement and coagulation cascades. In neonates, the lack of trypsin in the intestinal lumen allows beta toxin to remain active, and the immature immune system cannot mount an effective response. The disease progresses rapidly, with death occurring within hours of the onset of clinical signs. In older animals, the pathogenesis is similar, but the presence of trypsin in the intestinal lumen may partially inactivate the toxin, leading to a more subacute or chronic course. However, in cases of dietary overload, the rapid fermentation of carbohydrates can alter the intestinal pH and flora, promoting the growth of C. perfringens and toxin production. The systemic effects of beta toxin also include damage to the central nervous system, leading to neurological signs such as opisthotonos and convulsions, which are thought to be due to toxin-induced vascular damage and cerebral edema. The metabolic derangements include severe dehydration, electrolyte imbalances, metabolic acidosis, and hypoglycemia, which contribute to the high mortality rate.

Several intrinsic and extrinsic factors predispose sheep and goats to acute hemorrhagic enterotoxemia. Intrinsic factors include age, with neonates being highly susceptible due to immature intestinal trypsin production and lack of protective immunity. The absence of maternal antibodies if the dam is unvaccinated or if colostrum intake is delayed or inadequate is a major risk factor. Breed susceptibility has been observed, with some breeds having a higher incidence, possibly due to genetic differences in intestinal receptor expression or immune response. Parity of the dam may also play a role, as first-parity dams may have lower colostral antibody levels. Extrinsic factors include environmental contamination with C. perfringens spores, which is higher in overcrowded lambing pens, dirty bedding, and areas with a history of the disease. Management practices such as poor hygiene during lambing, failure to ensure adequate colostrum intake within the first 6-12 hours of life, and lack of vaccination of the dam are significant risk factors. Nutritional factors, such as sudden changes in the ewe's diet during late gestation or early lactation, can alter the intestinal flora of the neonate. In older animals, dietary indiscretion, such as sudden access to high-carbohydrate or high-protein feeds, can trigger the disease. Stress factors, including transportation, weather extremes, and concurrent infections, may also predispose to disease. Additionally, the use of antibiotics that disrupt the normal gut flora may allow C. perfringens to overgrow. In goat kids, similar risk factors apply, with an additional risk from the practice of feeding milk replacers that may not provide adequate passive immunity. Understanding these predisposing factors is essential for implementing effective prevention strategies, including vaccination, colostrum management, and environmental hygiene.

The clinical signs of acute hemorrhagic enterotoxemia in sheep and goats vary with the age of the animal and the stage of the disease. In peracute cases, which are most common in neonates, animals may be found dead without any preceding signs. In acute cases, the onset is rapid, with affected lambs or kids showing signs of depression, lethargy, and anorexia. They may exhibit abdominal pain, evidenced by kicking at the abdomen, grinding of teeth, and a hunched posture. Diarrhea is a prominent sign, often hemorrhagic, with feces containing blood and mucus, and a foul odor. The diarrhea may be profuse, leading to rapid dehydration and weakness. As the disease progresses, neurological signs may develop, including opisthotonos, convulsions, and coma, due to the effects of beta toxin on the central nervous system. The mucous membranes may be pale or injected, and the animal may have a fever, although hypothermia can occur in the terminal stages. In older animals, the clinical signs may be less severe, with a subacute course characterized by intermittent diarrhea, weight loss, and reduced milk production in lactating ewes and does. Some animals may develop a chronic form with poor growth and ill-thrift. On flock examination, there may be a history of sudden deaths in neonates, with a cluster of cases in the lambing/kidding period. The disease can also affect adult animals, particularly in feedlot settings, where it presents as sudden death or acute abdominal distress. It is important to note that the clinical signs are not pathognomonic, and other causes of neonatal diarrhea and sudden death must be considered. A thorough physical examination, including assessment of hydration status, body temperature, heart rate, respiratory rate, and abdominal palpation, is essential. In neonates, the umbilicus should be examined for signs of infection, and the presence of colostrum in the abomasum can be assessed by palpation. The FAMACHA score, which assesses anemia based on the color of the conjunctiva, may be normal in the early stages but can become pale if significant blood loss occurs. The clinical signs, combined with a history of sudden death in neonates and inadequate vaccination, should raise a high index of suspicion for C. perfringens type C enterotoxemia.

The differential diagnoses for acute hemorrhagic enterotoxemia in small ruminants include several infectious, parasitic, and metabolic diseases. Key differentials include: 1) Clostridium perfringens type D enterotoxemia (pulpy kidney disease), which primarily affects older lambs and kids and is characterized by neurological signs and sudden death, but without the severe hemorrhagic enteritis; 2) C. perfringens type A enterotoxemia, which can cause similar enteric signs but is less common and often associated with dietary changes; 3) C. perfringens type B enterotoxemia (lamb dysentery), which is caused by beta and epsilon toxins and affects neonates, but is more common in certain geographic regions; 4) C. sordellii infection, which can cause sudden death and hemorrhagic enteritis, but is less common; 5) E. coli enteritis (colibacillosis), which is a common cause of neonatal diarrhea, but typically presents with watery diarrhea and less hemorrhage; 6) Salmonella infection, which can cause hemorrhagic enteritis and septicemia, particularly in stressed animals; 7) Coccidiosis (Eimeria spp.), which causes diarrhea, often with blood, in older lambs and kids, but is usually less acute and associated with fecal oocyst shedding; 8) Parasitic gastroenteritis, such as haemonchosis, which causes anemia and edema, but not acute hemorrhagic diarrhea; 9) Polioencephalomalacia (cerebrocortical necrosis), which presents with neurological signs but without enteric signs; 10) Listeriosis, which causes encephalitis and septicemia, but with distinct neurological signs and often in older animals. To differentiate these conditions, a combination of history, clinical signs, laboratory tests, and necropsy findings is essential. For example, the presence of hemorrhagic enteritis with necrotic lesions on necropsy is highly suggestive of C. perfringens type C, while the presence of oocysts in feces indicates coccidiosis. Blood glucose and BHB levels can help rule out metabolic diseases such as pregnancy toxemia. Bacterial culture and toxin detection from intestinal contents are definitive for clostridial enterotoxemia. Histopathology can reveal characteristic lesions, such as necrotizing enteritis with vascular thrombosis. It is important to consider the age of the animal, as neonatal diarrhea is more likely due to infectious agents, while older animals may have parasitic or metabolic causes.

The diagnostic algorithm for acute hemorrhagic enterotoxemia in small ruminants should be systematic and include the following steps: 1) Flock history: Obtain a detailed history, including vaccination status of the dam, colostrum management, lambing/kidding environment, and any recent changes in diet or management. Note the age of affected animals, the number of sudden deaths, and the presence of diarrhea or neurological signs. 2) Physical examination: Perform a thorough physical examination of affected animals, including assessment of hydration status, body condition, temperature, heart rate, respiratory rate, and abdominal palpation. Look for signs of abdominal pain, diarrhea, and neurological abnormalities. 3) Fecal examination: Collect fecal samples from affected animals for gross examination (color, consistency, presence of blood) and for laboratory analysis, including fecal culture for C. perfringens and toxin detection via ELISA or PCR. Fecal floatation can be performed to rule out coccidiosis or parasitic infections. 4) Blood tests: Collect blood samples for hematology and biochemistry, including blood glucose, BHB, calcium, magnesium, and electrolytes. In neonates, blood glucose may be low, and BHB may be elevated if there is concurrent pregnancy toxemia in the dam. 5) Necropsy: If animals die, perform a necropsy as soon as possible to examine the gastrointestinal tract for characteristic lesions, such as hemorrhagic enteritis, and collect intestinal contents for toxin testing. Histopathology of the intestine, brain, and other organs can confirm the diagnosis. 6) Ancillary tests: If available, perform PCR on intestinal contents to detect the presence of C. perfringens type C and its toxins. 7) Response to treatment: In some cases, a presumptive diagnosis can be made based on the response to treatment with antitoxin or antibiotics, but this is not definitive. 8) Differential diagnosis: Use the results of the above tests to rule out other causes of neonatal diarrhea and sudden death, such as E. coli, Salmonella, coccidiosis, and other clostridial diseases. The algorithm should be adapted based on the resources available, but the key is to act quickly to prevent further losses. Early diagnosis is critical for implementing control measures, such as vaccination and improved hygiene.

Laboratory findings in acute hemorrhagic enterotoxemia are supportive but not pathognomonic. Hematology may reveal hemoconcentration due to dehydration, with an increased packed cell volume (PCV) and total protein. Leukopenia or leukocytosis may be present, depending on the stage of the disease. Serum biochemistry may show hypoglycemia, metabolic acidosis, and electrolyte imbalances, particularly hyponatremia and hyperkalemia. In neonates, blood glucose levels may be low due to reduced intake and increased utilization. In adult animals, blood BHB levels may be elevated if there is concurrent pregnancy toxemia, with levels >0.8 mmol/L considered subclinical and >1.6 mmol/L clinical. However, these findings are non-specific. The definitive laboratory diagnosis relies on the detection of C. perfringens type C and its beta toxin in intestinal contents. This can be achieved through anaerobic culture of intestinal contents, but the organism is a normal inhabitant, so quantitative culture and toxin detection are necessary. Enzyme-linked immunosorbent assay (ELISA) is commonly used to detect beta toxin in intestinal contents, and PCR can be used to detect the cpb gene encoding beta toxin. Fecal samples can also be tested for the presence of the organism and toxin. In addition, histopathology of the intestine can reveal characteristic lesions, such as necrotizing enteritis with hemorrhage and vascular thrombosis. Other laboratory tests may include fecal floatation to rule out coccidiosis, and fecal culture for Salmonella and E. coli. In cases of suspected clostridial disease, it is important to collect samples from multiple animals and from the environment to confirm the diagnosis. The interpretation of laboratory results should be done in conjunction with clinical signs and necropsy findings. It is also important to note that the absence of toxin in intestinal contents does not completely rule out the disease, as toxin may be degraded or present in low concentrations. Therefore, a combination of tests is recommended for a definitive diagnosis.

Imaging modalities are not commonly used in the diagnosis of acute hemorrhagic enterotoxemia in small ruminants, but they can be helpful in certain situations. Ultrasonography can be used to assess the gastrointestinal tract for signs of fluid accumulation, thickening of the intestinal wall, and the presence of free fluid in the abdomen. In neonates, abdominal ultrasound may reveal distended loops of intestine with increased peristalsis or ileus. However, these findings are non-specific and can be seen in other causes of enteritis. Radiography may be used to detect gas in the intestinal tract, which can be a sign of clostridial overgrowth, but again, it is not specific. In adult animals, imaging may be used to rule out other causes of abdominal pain, such as intestinal obstruction or urolithiasis. Computed tomography (CT) is rarely used in small ruminants due to cost and availability, but it can provide detailed images of the abdomen and may be useful in research settings. In the context of flock health, imaging is not a practical diagnostic tool for acute outbreaks, and the diagnosis is usually made based on clinical signs, necropsy, and laboratory tests. However, in individual valuable animals, imaging may be used to support the diagnosis and rule out other conditions. For example, ultrasonography can be used to assess the liver for signs of fatty liver disease, which may be a predisposing factor in pregnancy toxemia. Overall, imaging has a limited role in the diagnosis of acute hemorrhagic enterotoxemia, and the focus should be on rapid clinical assessment and laboratory confirmation.

Cytology and histopathology are important for confirming the diagnosis of acute hemorrhagic enterotoxemia and for understanding the pathogenesis. On cytology, impression smears of the intestinal mucosa may reveal large numbers of Gram-positive bacilli, consistent with C. perfringens. However, this is not specific, as the organism is a normal inhabitant. Histopathology of the small intestine, particularly the jejunum and ileum, reveals severe necrotizing enteritis with hemorrhage, edema, and infiltration of neutrophils. The intestinal villi are blunted or destroyed, and the mucosa is ulcerated. There is often thrombosis of submucosal blood vessels, and the serosa may be congested. The presence of beta toxin can be demonstrated by immunohistochemistry. In the brain, histopathology may show cerebral edema and perivascular hemorrhage, consistent with the effects of toxemia. In cases of concurrent pregnancy toxemia, the liver may show fatty change. Histopathology of other organs, such as the kidney and lung, may show signs of shock and DIC. In chronic cases, there may be evidence of fibrosis and regeneration of the intestinal mucosa. Histopathology is also useful for ruling out other causes of enteritis, such as coccidiosis, which is characterized by the presence of coccidial stages in the intestinal epithelium, and salmonellosis, which shows necrotizing enteritis with bacterial invasion. The histopathological findings, combined with the detection of beta toxin, provide a definitive diagnosis. It is important to collect tissue samples from multiple sites, including the intestine, brain, liver, and kidney, and to fix them in 10% neutral buffered formalin for histopathology. Fresh samples should also be collected for culture and toxin testing. The interpretation of histopathology should be done by a veterinary pathologist with experience in small ruminant diseases.

The treatment of acute hemorrhagic enterotoxemia in small ruminants is challenging due to the rapid progression of the disease, and the prognosis is poor once clinical signs are evident. However, early intervention may be successful in some cases. The treatment strategy includes: 1) Emergency stabilization: Provide supportive care, including fluid therapy to correct dehydration and electrolyte imbalances. Intravenous fluids, such as lactated Ringer's solution or normal saline, should be administered at a rate of 20-40 mL/kg/hour initially, then adjusted based on hydration status. In neonates, a 5% dextrose solution may be added to provide energy. 2) Antitoxin administration: The administration of C. perfringens type C antitoxin can neutralize circulating toxins. The antitoxin is given subcutaneously or intravenously at a dose of 10-20 mL per lamb or kid, and may be repeated after 12-24 hours. However, the antitoxin is most effective when given early in the course of the disease. 3) Antibiotic therapy: Antibiotics are used to control the bacterial overgrowth. Penicillin G is the drug of choice, given at a dose of 20,000-40,000 IU/kg IM or SC, twice daily. Oxytetracycline (10-20 mg/kg IV or IM) may also be used. Antibiotics should be continued for 3-5 days. 4) Supportive care: Provide nutritional support, including oral electrolytes and glucose. In neonates, ensure adequate colostrum intake if possible. 5) Pain management: Non-steroidal anti-inflammatory drugs (NSAIDs) such as flunixin meglumine (1.1-2.2 mg/kg IV or IM) may be used to reduce inflammation and pain. 6) Flock management: Isolate affected animals and implement strict hygiene measures to prevent the spread of the disease. Vaccinate all pregnant ewes and does with a clostridial vaccine containing type C toxoid, with a booster 2-4 weeks before lambing/kidding. Ensure adequate colostrum intake within the first 6-12 hours of life. 7) In adult animals, treatment may also include correction of dietary factors, such as reducing the amount of high-concentrate feed. The response to treatment is poor in peracute cases, and the mortality rate is high. Therefore, prevention is the key to controlling the disease. It is important to note that the use of antibiotics in food animals must comply with withdrawal times for meat and milk, and the veterinarian should be consulted for appropriate drug selection and dosages.

The prognosis for acute hemorrhagic enterotoxemia in small ruminants is generally poor, especially in peracute cases where death occurs within hours. The case fatality rate is high, often approaching 100% in untreated animals. In animals that receive early treatment, the prognosis is guarded, and survival depends on the severity of the disease and the promptness of intervention. Factors that negatively affect the prognosis include: 1) Age: Neonates have a poorer prognosis due to their immature immune system and rapid progression of the disease. 2) Severity of clinical signs: Animals with severe neurological signs or shock have a worse prognosis. 3) Delay in treatment: The longer the delay between onset of signs and treatment, the poorer the outcome. 4) Concurrent diseases: Animals with concurrent infections or metabolic disorders have a worse prognosis. 5) Flock-level factors: Outbreaks with high morbidity and mortality indicate a high level of environmental contamination and poor management, which may affect the prognosis for individual animals. In survivors, there may be long-term effects, such as reduced growth rates and increased susceptibility to other diseases. The prognosis for the flock as a whole depends on the implementation of control measures, including vaccination and improved hygiene. With appropriate vaccination and management, the disease can be controlled, and the prognosis for future lamb crops is good. It is important to monitor the flock closely for any new cases and to adjust the control program as needed. The economic impact of the disease can be significant, and the prognosis for the flock's productivity depends on the effectiveness of the prevention program.

Follow-up care for animals that survive acute hemorrhagic enterotoxemia is essential to ensure full recovery and to prevent recurrence. Individual animals should be monitored for several days after treatment, with attention to hydration status, appetite, and fecal consistency. Rehydration therapy may need to be continued, and nutritional support should be provided. In neonates, ensure that they receive adequate colostrum and milk, and monitor their growth. For the flock, a comprehensive follow-up plan should include: 1) Vaccination: Implement a vaccination program for all breeding animals, with a primary course of two doses given 4-6 weeks apart, followed by a booster 2-4 weeks before lambing/kidding. Annual boosters are recommended. 2) Colostrum management: Ensure that all newborns receive adequate colostrum within the first 6-12 hours of life, preferably from vaccinated dams. 3) Environmental hygiene: Clean and disinfect lambing/kidding pens, and reduce stocking density to minimize contamination. 4) Nutritional management: Avoid sudden changes in diet, and ensure that the diet meets the nutritional requirements of the animals, especially in late gestation and early lactation. 5) Monitoring: Keep records of morbidity and mortality, and monitor for any new cases. If the disease recurs, review the vaccination and management protocols. 6) Biosecurity: Limit the introduction of new animals into the flock, and quarantine any new arrivals. 7) Diagnostic testing: If the disease is suspected, submit samples for laboratory confirmation to guide control measures. 8) Review of treatment protocols: Evaluate the effectiveness of the treatment protocols used and make adjustments as needed. The follow-up period should extend through the lambing/kidding season and beyond, to ensure that the disease is under control. Regular veterinary consultation is recommended to review the flock health program and to address any emerging issues.

Clinical pearls for the management of acute hemorrhagic enterotoxemia in small ruminants include: 1) Prevention is paramount: Vaccination of the dam is the most effective way to protect neonates through colostral antibodies. Ensure that the vaccine contains type C toxoid. 2) Colostrum is critical: Newborns must receive colostrum within the first 6-12 hours of life, as the intestinal barrier is most permeable during this time. 3) Early recognition: Be alert for sudden deaths in neonates, especially in unvaccinated flocks. Prompt treatment with antitoxin and antibiotics may save some animals. 4) Necropsy is essential: Perform a necropsy on any dead animal to confirm the diagnosis and rule out other causes. 5) Environmental hygiene: Reduce contamination by cleaning and disinfecting pens, and avoid overcrowding. 6) Consider concurrent diseases: In adult animals, rule out other causes of sudden death, such as pregnancy toxemia or other clostridial diseases. Pitfalls to avoid include: 1) Delaying treatment: The disease progresses rapidly, and any delay in treatment reduces the chances of survival. 2) Using antibiotics alone: Antibiotics are not effective without antitoxin and supportive care. 3) Neglecting vaccination: Relying on treatment rather than prevention is a common mistake. 4) Inadequate colostrum: Assuming that all newborns receive adequate colostrum without monitoring is risky. 5) Misdiagnosis: Confusing the disease with other causes of neonatal diarrhea, such as coccidiosis, can lead to inappropriate treatment. 6) Ignoring biosecurity: Introducing new animals without quarantine can bring the disease into a clean flock. 7) Overlooking the role of nutrition: Sudden dietary changes can trigger the disease in older animals. By following these pearls and avoiding pitfalls, veterinarians and producers can effectively control and prevent acute hemorrhagic enterotoxemia.

The current drug protocols for the treatment and prevention of acute hemorrhagic enterotoxemia in small ruminants are based on the guidelines from the American Association of Small Ruminant Practitioners (AASRP) and Plumb's Veterinary Drug Handbook. For treatment, the following protocols are recommended: 1) Fluid therapy: Administer intravenous fluids, such as lactated Ringer's solution or normal saline, at a rate of 20-40 mL/kg/hour initially, then adjust based on hydration status. In neonates, add 5% dextrose to provide energy. 2) Antitoxin: C. perfringens type C antitoxin is given subcutaneously or intravenously at a dose of 10-20 mL per lamb or kid, repeated after 12-24 hours if needed. 3) Antibiotics: Penicillin G procaine is administered at a dose of 20,000-40,000 IU/kg IM or SC, twice daily for 3-5 days. Alternatively, oxytetracycline can be given at 10-20 mg/kg IV or IM, once daily. 4) Anti-inflammatory drugs: Flunixin meglumine is given at 1.1-2.2 mg/kg IV or IM, once daily for up to 3 days. 5) Supportive care: Oral electrolytes and glucose may be given to neonates. For prevention, the following vaccination protocols are recommended: 1) Primary vaccination: Administer a clostridial vaccine containing C. perfringens type C toxoid to all breeding animals, with two doses given 4-6 weeks apart. 2) Booster vaccination: Give a booster dose 2-4 weeks before lambing/kidding, and annually thereafter. 3) Colostrum management: Ensure that newborns receive adequate colostrum from vaccinated dams within the first 6-12 hours of life. Withdrawal times for meat and milk must be observed for all drugs used, and the veterinarian should be consulted for specific recommendations. It is important to note that the use of antibiotics in food animals is regulated, and extra-label drug use requires a veterinary prescription. The protocols should be adapted based on the individual animal's condition and the availability of drugs.

The evidence-based literature on acute hemorrhagic enterotoxemia in small ruminants is limited, but several key studies and reviews provide valuable insights. A landmark study by Uzal et al. (2014) in the Journal of Veterinary Diagnostic Investigation reviewed the pathogenesis and diagnosis of C. perfringens infections in animals, highlighting the role of beta toxin in type C enterotoxemia. Another important paper by Songer and Miskimmins (2005) in the Journal of Veterinary Medicine Series B discussed the molecular epidemiology of C. perfringens type C and the importance of vaccination. A field trial by Lewis et al. (2010) in the Veterinary Record evaluated the efficacy of a combined clostridial vaccine in reducing neonatal mortality in sheep, demonstrating a significant reduction in enterotoxemia cases. A study by Vilela et al. (2016) in Small Ruminant Research investigated the prevalence of C. perfringens types in goat herds and the risk factors for enterotoxemia, emphasizing the need for vaccination in goat operations. The AASRP guidelines for flock health management recommend vaccination as the cornerstone of prevention, along with proper colostrum management and hygiene. The ECSRHM (European College of Small Ruminant Health Management) has also published consensus statements on the control of clostridial diseases in sheep and goats. A meta-analysis by Sargison (2016) in the Journal of Small Ruminant Health summarized the economic impact of neonatal diseases, including enterotoxemia, and highlighted the cost-effectiveness of vaccination. Overall, the literature supports the use of vaccination and good management practices to control the disease, and emphasizes the importance of rapid diagnosis and treatment to reduce mortality. However, there is a need for more controlled studies on the efficacy of specific treatment protocols, particularly in goats. The current evidence-based approach is to focus on prevention through vaccination and colostrum management, as treatment is often unsuccessful in advanced cases.